---
category: news
title: "Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid ..."
excerpt: "Alexis ISO-1 is Companyâ€™s First Artificial Intelligence-identified, Gamma Delta T Cell Engineered Iso-Mesothelin Candidate to Address Solid Tumor Cancers HOUSTON-- ( BUSINESS WIRE )--Kiromic BioPharma,"
publishedDateTime: 2021-10-11T16:02:00Z
originalUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
webUrl: "https://www.businesswire.com/news/home/20211011005172/en/Kiromic-BioPharma-Announces-Strategic-Collaboration-with-Gemelli-Teaching-Hospital-to-Accelerate-the-Analysis-of-Allogeneic-CAR-T-Clinical-Trial-Candidate-Alexis-ISO-1-in-Solid-Cancers"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "u4zds2Jgsmjh0+npUISwdoslfuAUiBsUI3wKa2j16hh2THb5sjUiYxVeLH3Y78v5cSFmMCjA4bvIuF6eYmT1x9pncmGUPArPplyGE8ya3+ziNhoIeI7MKcZVWhqo9/UPXMHlNIRHb1550Q/gwQnQ2zludJZvoAdsTg7ErPP5jsmWo9OYgVjnq7ECH9U4Ku6P5fEMzMr78b5d5Vfp0uWHtpiWBs2AddpdJG6c4+ucxvd3zZbYzXjXX3Wg/kJRHieLZQqnTkXuwadbxl7+pgGVvwnW/AktahgNhA1U7vsf7YREXJ8X5tRGj2T4J9ESWAWmUpFsqh0s/h9r0M6x/zeDnvf1pHNW1JSNexRFS5yj+x8=;C5J1lV6Fjl82pDKEznz/DA=="
---

